Italfarmaco Sa patents expiration
1. Tiglutik Kit patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8765150 | ITALFARMACO SA | Riluzole aqueous suspensions |
Mar, 2029
(4 years from now) | |
Drugs and Companies using RILUZOLE ingredient
Market Authorisation Date: 05 September, 2018
Treatment: A method of treating amyotrophic lateral sclerosis in a patient in need of such treatment, said method comprising administering to said patient an effective amount of a suspension according to claim 1
Dosage: SUSPENSION;ORAL
How can I launch a generic of TIGLUTIK KIT before it's drug patent expiration?
More Information on Dosage
TIGLUTIK KIT family patents
